US Broker Ratings

Amgen Inc. (AMGN) Stock Analysis: Evaluating the 101% Return on Equity Amid a Diverse Portfolio

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, continues to capture investor attention with its robust portfolio of therapeutics and impressive financial metrics. As..

Abbott Laboratories (ABT) Stock Analysis: A Healthcare Giant with a 22.35% Upside Potential

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, continues to attract investor attention with its robust portfolio of medical devices and healthcare products. With..

Vertex Pharmaceuticals (VRTX) Stock Analysis: A Biotech Giant with a 3.91% Upside Potential

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a formidable player in the biotechnology sector, renowned for its pioneering work in developing treatments for serious diseases such..

Johnson & Johnson (JNJ) Stock Analysis: A Healthcare Giant with a 26.42% ROE and Steady Dividend Yield

Johnson & Johnson (NYSE: JNJ) remains a stalwart in the healthcare sector, commanding a market capitalization of $633.19 billion. Known for its diverse portfolio in the..

Option Care Health, Inc. (OPCH) Stock Analysis: A 31% Upside Potential Amid Strong Buy Ratings

Investors looking for promising opportunities in the healthcare sector may want to closely examine Option Care Health, Inc. (NASDAQ: OPCH), a key player in the medical..

Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring a Potential 92.85% Upside in the Biotech Sector

Vaxcyte, Inc. (NASDAQ: PCVX) has recently captured investor attention with its promising position in the biotech sector, driven by innovative vaccine development and significant upside potential...

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Evaluating Growth Amidst Stable Price Movements

Bio-Rad Laboratories, Inc. (NYSE: BIO) stands out as a key player in the healthcare sector, specifically within the medical devices industry. With a robust market capitalization..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Unveiling a 35% Upside Potential with Robust Analyst Ratings

Prestige Consumer Healthcare Inc. (PBH), a key player in the healthcare sector, is making waves with its diverse portfolio of over-the-counter (OTC) health and personal care..

Waystar Holding Corp. (WAY) Stock Analysis: Exploring a Potential 69% Upside in the Healthcare Tech Space

For investors looking at the intersection of healthcare and technology, Waystar Holding Corp. (NASDAQ: WAY) presents an intriguing opportunity. Specializing in cloud-based software solutions for healthcare..

Legend Biotech Corporation (LEGN) Stock Analysis: Exploring a Potential 100% Upside in the Biotech Sector

Legend Biotech Corporation (NASDAQ: LEGN) is making waves in the biotechnology sector, particularly with its promising pipeline of novel cell therapies. Despite the challenges inherent in..

Atrium Therapeutics, Inc. (RNA) Stock Analysis: A Biotech Company Poised for Nearly 90% Upside

Atrium Therapeutics, Inc. (NASDAQ: RNA) stands as a compelling opportunity within the biotechnology sector, particularly for investors with an appetite for high-growth potential. With a market..

Incyte Corporation (INCY) Stock Analysis: A Biotech Powerhouse with Robust Revenue Growth and Strategic Collaborations

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology sector, has carved a niche for itself in the healthcare industry through its innovative approach to..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: A Stable Horizon with Strong Cash Reserves

Soleno Therapeutics, Inc. (NASDAQ: SLNO), a prominent player in the biotechnology sector, commands a market capitalization of $2.76 billion. Headquartered in Redwood City, California, Soleno Therapeutics..

Oscar Health, Inc. (OSCR) Stock Analysis: Exploring the 52.60% Revenue Growth in the Expanding Healthcare Sector

Oscar Health, Inc. (OSCR) is making waves in the healthcare sector, capturing investor attention with an impressive 52.60% revenue growth. Headquartered in New York, Oscar Health..

Krystal Biotech, Inc. (KRYS) Stock Analysis: A Biotech Marvel with 31.9% Revenue Growth and Strong Buy Ratings

Krystal Biotech, Inc. (NASDAQ: KRYS) has emerged as a formidable player in the biotechnology sector, with a market capitalization of $10.97 billion. Specializing in genetic medicines..

HealthEquity, Inc. (HQY) Stock Analysis: Strong Buy Ratings Signal a Potential 30% Upside for Investors

HealthEquity, Inc. (NASDAQ: HQY), a leader in the Health Information Services industry, is capturing the attention of investors with its robust growth potential and favorable analyst..

Avantor, Inc. (AVTR) Stock Analysis: Navigating Potential Upside Amidst Market Challenges

Avantor, Inc. (NYSE: AVTR) stands as a pivotal player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of..

Tempus AI, Inc. (TEM) Stock Analysis: Growth Prospects Amidst a Complex Financial Landscape

Tempus AI, Inc. (TEM), a healthcare technology company headquartered in Chicago, Illinois, is making waves in the health information services industry with its innovative solutions and..

DaVita Inc. (DVA) Stock Analysis: Evaluating the Healthcare Giant’s 80.98% ROE and Market Dynamics

DaVita Inc. (NYSE: DVA), a leader in the healthcare sector with a focus on medical care facilities, has been a subject of keen investor interest, particularly..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating a 11.37% Potential Upside Amidst Mixed Analyst Ratings

Inspire Medical Systems, Inc. (NASDAQ: INSP) has been capturing investor attention as it operates at the cutting edge of medical technology, particularly in the treatment of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds